BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1751375)

  • 21. von Willebrand factor-cleaving protease in childhood diarrhoea-associated haemolytic uraemic syndrome.
    Hunt BJ; Lämmle B; Nevard CH; Haycock GB; Furlan M
    Thromb Haemost; 2001 Jun; 85(6):975-8. PubMed ID: 11434704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical use of a rapid collagen binding assay for von Willebrand factor cleaving protease in patients with thrombotic thrombocytopenic purpura.
    Rick ME; Moll S; Taylor MA; Krizek DM; White GC; Aronson DL
    Thromb Haemost; 2002 Oct; 88(4):598-604. PubMed ID: 12362230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical analysis on thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, with plasma level of cytokine].
    Wada H; Saitoh M; Tamaki S; Masuya M; Morita K; Tabata M; Tanigawa M; Kageyama S; Tsuzi K; Ohta C
    Rinsho Ketsueki; 1990 Sep; 31(9):1537-43. PubMed ID: 2246829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombotic thrombocytopenic purpura: the systemic clumping "plague".
    Moake JL
    Annu Rev Med; 2002; 53():75-88. PubMed ID: 11818464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular mechanisms in thrombotic thrombocytopenic purpura.
    Tsai HM
    Semin Thromb Hemost; 2004 Oct; 30(5):549-57. PubMed ID: 15497097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
    Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G.
    Lian EC; Mui PT; Siddiqui FA; Chiu AY; Chiu LL
    J Clin Invest; 1984 Feb; 73(2):548-55. PubMed ID: 6538207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.
    Tsai HM; Lian EC
    N Engl J Med; 1998 Nov; 339(22):1585-94. PubMed ID: 9828246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells.
    Burns ER; Zucker-Franklin D
    Blood; 1982 Oct; 60(4):1030-7. PubMed ID: 7052160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between platelet aggregating factor and von Willebrand factor in thrombotic thrombocytopenic purpura.
    Murphy WG; Moore JC; Barr RD; Pai MK; Kelton JG
    Br J Haematol; 1987 Aug; 66(4):509-13. PubMed ID: 3499167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet aggregating factor in the epidemic form of hemolytic-uremic syndrome in childhood.
    Monnens L; van de Meer W; Langenhuysen C; van Munster P; van Oostrom C
    Clin Nephrol; 1985 Sep; 24(3):135-7. PubMed ID: 4042442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies.
    Moake J
    Best Pract Res Clin Haematol; 2009 Dec; 22(4):567-76. PubMed ID: 19959109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnostic criteria and differential diagnosis of thrombotic thrombocytopenic purpura].
    Pardo Vigo A; Zamora de Pedro C; Hernández Jodra M
    Rev Clin Esp; 2000 Dec; 200(12):685-7. PubMed ID: 11234475
    [No Abstract]   [Full Text] [Related]  

  • 35. Thrombotic thrombocytopenic purpura in childhood.
    Bouw MC; Dors N; van Ommen H; Ramakers-van Woerden NL
    Pediatr Blood Cancer; 2009 Oct; 53(4):537-42. PubMed ID: 19544391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology and treatment of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS).
    Kakishita E
    Int J Hematol; 2000 Jun; 71(4):320-7. PubMed ID: 10905050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of von Willebrand factor-cleaving protease activity in patients with thrombotic thrombocytopenic purpura.
    Gao WQ; Su J; Bai X; Wang ZY; Ruan CG
    Chin Med J (Engl); 2004 Jun; 117(6):818-22. PubMed ID: 15198879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombotic thrombocytopenic purpura: from platelet aggregates to plasma.
    Marques MB; Mayfield CA; Blackall DP
    Am J Clin Pathol; 2004 Jun; 121 Suppl():S89-96. PubMed ID: 15298154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma levels of the von Willebrand factor-cleaving protease in physiological and pathological conditions in children.
    Kavakli K; Canciani MT; Mannucci PM
    Pediatr Hematol Oncol; 2002; 19(7):467-73. PubMed ID: 12217192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.